Showing results (621-630 of 889) with videos related to
Sort By:
Pageof 89
Archives of Neurology|June 1, 1991
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophyG M Fenichel, J R Mendell, R T Moxley, et al.Nature Genetics|January 1, 1995
A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patientsT G Thompson, C J DiDonato, L R Simard, et al.Nature Genetics|December 11, 2007
Widespread microRNA repression by Myc contributes to tumorigenesisTsung-Cheng Chang, Duonan Yu, Yun-Sil Lee, et al.Emerging Infectious Diseases|June 22, 2023
Spotted Fever and Typhus Group Rickettsiae in Dogs and Humans, Mexico, 2022Ricardo Palacios-Santana, Lihua Wei, Nadia A Fernandez-Santos, et al.Neurology|March 1, 1993
Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)R C Griggs, R T Moxley, J R Mendell, et al.Epidemiology (Cambridge, Mass.)|April 20, 2002
Indoor particles and symptoms among office workers: results from a double-blind cross-over studyMark J Mendell, William J Fisk, Marty R Petersen, et al.Annals of Neurology|October 1, 1987
Genetic heterogeneity in Duchenne dystrophyC L Hyser, M Province, R C Griggs, et al.Neurology|March 1, 1993
Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophyJ T Kissel, D J Lynn, K W Rammohan, et al.Neurology|December 1, 1991
Long-term benefit from prednisone therapy in Duchenne muscular dystrophyG M Fenichel, J M Florence, A Pestronk, et al.Muscle & Nerve|January 17, 2012
Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositisLinda Pax Lowes, Lindsay Alfano, Laurence Viollet, et al.Pageof 89